Pemphigus Vulgaris Clinical Trials in Philadelphia, Pennsylvania
2 recruitingPhiladelphia, Pennsylvania
Showing 1–2 of 2 trials
Recruiting
Autoimmune Blistering Diseases Study
Pemphigus VulgarisPemphigus Foliaceus
University of Pennsylvania150 enrolled3 locationsNCT02753777
Recruiting
Phase 1Phase 2
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Pemphigus Vulgaris
Cabaletta Bio40 enrolled13 locationsNCT04422912